Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance

Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with frequent post-surgical local recurrence. The combination of adjuvant chemotherapy with radiotherapy is under consideration to achieve a prolonged progression-free survival (PFS). To date, few studies have determined the proteome profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oria, V.O., Bronsert, P., Thomsen, A.R., Föll, M.C., Zamboglou, C., Hannibal, L., Behringer, S., Biniossek, M.L., Schreiber, C., Grosu, A.L., Bolm, L., Rades, D., Keck, T., Werner, M., Wellner, U.F., Schilling, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121830/
https://www.ncbi.nlm.nih.gov/pubmed/30172883
http://dx.doi.org/10.1016/j.tranon.2018.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121830/
https://www.ncbi.nlm.nih.gov/pubmed/30172883
http://dx.doi.org/10.1016/j.tranon.2018.08.001

Ejemplares similares